The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...
A federal court recently blocked the Trump administration from moving forward with a proposed pilot program that could have saved patients, taxpayers and employers billions of dollars. But fortunately ...
This contributor column discusses a recent study that shows the 340B Program’s explosive growth is overwhelmingly due to utilization increases, not price. Payers have struggled with the increasing ...
The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.
For the 5,000 people in Illinois living with sickle cell disease, access to affordable medical care and life-saving treatments is necessary. Yet far too many still struggle to get the medications and ...
On July 31, 2025, the Health Resources and Services Administration (“HRSA”) announced the availability of a voluntary 340B Rebate Model Pilot Program (the “340B Rebate Pilot” or the “Pilot”) that ...
Add Yahoo as a preferred source to see more of our stories on Google. In a recent opinion piece, it was suggested the federal 340B Drug Pricing Program is contributing to rising employer health-care ...
The 340B Drug Pricing Program allows certain medical facilities to buy drugs at a discount to support care for low-income patients. Rhode Island's new law, Chapter 288, prevents drug makers from ...
An obscure, supposedly free federal program is blowing a hole in state budgets – by depriving state governments of billions in corporate tax revenue and inflating costs for their public employee ...
New York lawmakers should heed the warning and respond. Real reforms of the 340B program cannot wait.
The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...
The 340B drug discount program incentivizes hospitals to purchase outpatient clinics and prescribe more and higher-cost drugs — behaviors that tend to increase costs for the federal government and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results